In vivo, CYP4A11 transfection significantly increased tumor weight, microvessel density, and lung metastasis, whereas HET0016 or 6,15,20-HEDE administration decreased tumor volume, microvessel density, and spontaneous pulmonary metastasis occurrences [206]. Here, CYP4A11 is linked to neoplasm.